Proceedings of the National Academy of Sciences · 2010 · 216 citations · 22 references
Life SciencesBiochemistryMolecular BiologyHemostasisNeurodegenerationStructural BiologyAlzheimer DiseaseAmyloid FormationFibrin FormationNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid FibrilsAmyloid Oligomer FormationAmyloid PlaquesFibrin Clot FormationFibrinogen Structure
Increasing evidence supports a vascular contribution to Alzheimer's disease (AD), but a direct connection between AD and the circulatory system has not been established. Previous work has shown that blood clots formed in the presence of the β-amyloid peptide (Aβ), which has been implicated in AD, have an abnormal structure and are resistant to degradation in vitro and in vivo. In the present study, we show that Aβ specifically interacts with fibrinogen with a K(d) of 26.3 ± 6.7 nM, that the binding site is located near the C terminus of the fibrinogen β-chain, and that the binding causes fibrinogen to oligomerize. These results suggest that the interaction between Aβ and fibrinogen modifies fibrinogen's structure, which may then lead to abnormal fibrin clot formation. Overall, our study indicates that the interaction between Aβ and fibrinogen may be an important contributor to the vascular abnormalities found in AD.
22
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
James Cleary, Dominic M. Walsh, J. Hofmeister et al. · Nature Neuroscience · 2004 · 1.7K citations
AlanRobert Gurd, R. I. Wilson · The Lancet · 1972 · 526 citations
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Anne Clark, Claire E. Lewis, A.C. Willis et al. · The Lancet · 1987 · 357 citations
Medicine, Endocrinology, Pathology +10